Berenberg raised the firm’s price target on Novo Nordisk to DKK 900 from DKK 850 and keeps a Hold rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVO:
- Novo Nordisk Advances Share Buyback Program
- Eli Lilly’s (NYSE:LLY) Weight-Loss Drug Outshines Wegovy for First Time
- Piper Sandler healthcare/pharma analysts hold analyst/industry conference call
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- European Stocks: Unnoticed Records, Overlooked Opportunities